Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.13
0.041.91%
At close: Jan 12, 4:00 PM EST
$2.13
N/A
After Hours: 7:05 PM EST
Comments
Loading...
Microbot Medical Analyst Ratings and Price Targets | NASDAQ:MBOT | Benzinga
Microbot Medical Inc has a consensus price target of $8.75 based on the ratings of 2 analysts. The high is $12 issued by HC Wainwright & Co. on November 28, 2025. The low is $5.5 issued by Roth Capital on December 3, 2025. The 3 most-recent analyst ratings were released by Roth Capital, HC Wainwright & Co., and HC Wainwright & Co. on December 3, 2025, November 28, 2025, and October 15, 2025, respectively. With an average price target of $9.83 between Roth Capital, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 361.66% upside for Microbot Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth Capital
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Microbot Medical
FAQ
What is the target price for Microbot Medical (MBOT) stock?
The latest price target for Microbot Medical (NASDAQ:MBOT) was reported by Roth Capital on December 3, 2025. The analyst firm set a price target for $5.50 expecting MBOT to rise to within 12 months (a possible 158.22% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Microbot Medical (MBOT)?
The latest analyst rating for Microbot Medical (NASDAQ:MBOT) was provided by Roth Capital, and Microbot Medical initiated their buy rating.
When was the last upgrade for Microbot Medical (MBOT)?
There is no last upgrade for Microbot Medical
When was the last downgrade for Microbot Medical (MBOT)?
There is no last downgrade for Microbot Medical.
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on December 3, 2025 so you should expect the next rating to be made available sometime around December 3, 2026.
Is the Analyst Rating Microbot Medical (MBOT) correct?
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a initiated with a price target of $0.00 to $5.50. The current price Microbot Medical (MBOT) is trading at is $2.13, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
